0001415889-23-014680.txt : 20231101 0001415889-23-014680.hdr.sgml : 20231101 20231101183545 ACCESSION NUMBER: 0001415889-23-014680 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231030 FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAHAM RICHARD A CENTRAL INDEX KEY: 0001820036 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36033 FILM NUMBER: 231369501 MAIL ADDRESS: STREET 1: 901 GATEWAY BLVD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Theravance Biopharma, Inc. CENTRAL INDEX KEY: 0001583107 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 BUSINESS PHONE: 650-808-6000 MAIL ADDRESS: STREET 1: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-1104 4 1 form4-11012023_101136.xml X0508 4 2023-10-30 0001583107 Theravance Biopharma, Inc. TBPH 0001820036 GRAHAM RICHARD A C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 false true false false SVP, RESEARCH & DEVELOPMENT 0 Ordinary Shares 2023-10-30 4 A 0 15000 0 A 349321 D On March 1, 2023 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of a performance condition by December 31, 2023 and continued employment. On October 30, 2023 the performance conditions were achieved. As a result 50% of the restricted stock units will vest on November 20, 2023 and the remaining 50% of the restricted stock units will vest on November 20, 2024, subject to the reporting person's continued service. /s/ Brett A. Grimaud, Attorney-in-Fact 2023-11-01